Susquehanna International Group, LLP Cyclerion Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	BUY	$0.43 - $0.9 $11,232 - $23,509	26,122 Added 137.11%	45,174 $19,000
Q4 2022 Feb 14, 2023	SELL	$0.42 - $18.8 $3,254 - $145,681	-7,749 Reduced 28.91%	19,052 $12,000
Q3 2022 Nov 14, 2022	SELL	$0.58 - $18.2 $2,989 - $93,821	-5,155 Reduced 16.13%	26,801 $23,000
Q2 2022 Aug 15, 2022	BUY	$0.47 - $1.29 $5,698 - $15,639	12,124 Added 61.13%	31,956 $18,000
Q1 2022 May 16, 2022	SELL	$0.96 - $1.78 $7,754 - $14,378	-8,078 Reduced 28.94%	19,832 $22,000
Q4 2021 Feb 14, 2022	SELL	$1.56 - $2.99 $42,773 - $81,982	-27,419 Reduced 49.56%	27,910 $48,000
Q3 2021 Nov 15, 2021	SELL	$2.73 - $4.13 $67,835 - $102,622	-24,848 Reduced 30.99%	55,329 $170,000
Q2 2021 Aug 11, 2021	BUY	$2.18 - $4.29 $114,517 - $225,357	52,531 Added 190.01%	80,177 $313,000
Q1 2021 May 17, 2021	BUY	$2.69 - $5.12 $15,152 - $28,840	5,633 Added 25.59%	27,646 $77,000
Q4 2020 Feb 16, 2021	BUY	$2.25 - $7.12 $25,265 - $79,950	11,229 Added 104.13%	22,013 $67,000
Q3 2020 Nov 16, 2020	BUY	$3.46 - $8.39 $37,312 - $90,477	10,784 New	10,784 $66,000
Q1 2020 May 15, 2020	SELL	$2.46 - $5.84 $44,845 - $106,463	-18,230 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.8 - $13.43 $13,861 - $103,424	7,701 Added 73.14%	18,230 $50,000
Q3 2019 Nov 14, 2019	SELL	$8.12 - $14.54 $10,369 - $18,567	-1,277 Reduced 10.82%	10,529 $128,000
Q2 2019 Aug 16, 2019	BUY	$9.6 - $22.85 $113,337 - $269,767	11,806 New	11,806 $135,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $112M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.